Radiotherapy Combined Chimeric Antigen Receptor T-Cells Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma(R/R DLBCL)

被引：0
|
作者：
Zhou, Lili [1 ]
Liu, Yifan [1 ]
Ye, Shiguang [1 ]
Li, Ping [1 ]
Li, Shaoguang [2 ]
Liang, Aibin [1 ]
机构：
[1] Tongji Univ, Tongji Hosp, Dept Hematol, Shanghai, Peoples R China
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184352
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A 'Real-World' Analysis of Patterns of Failure and Role of Bridging Therapy
    Ravella, Revathi
    Zhang-Velten, Elizabeth Ren
    Awan, Farrukh T.
    Rizvi, Syed M.
    Shah, Jennifer L.
    Desai, Neil B.
    Geethakumari, Praveen Ramakrishnan
    Kumar, Kiran A.
    BLOOD, 2020, 136
  • [42] Estimating the Impact on Survival of Not Receiving CAR T Therapy Despite Being Eligible in Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Patients in Germany
    Buecklein, Veit L.
    Ayuk, Francis A.
    Holderried, Tobias A. W.
    Mai, Christine
    Kievit, Bradley
    Blisset, Rob
    Doble, Brett
    Reid, Geoff
    Reimeir, Laura
    Bruns, Caroline
    Vadgama, Sachin
    BLOOD, 2024, 144 : 5037 - 5038
  • [43] Salvage therapy R-DAOx in patients with relapsed or refractory diffuse large B-CELL lymphoma
    Mappa, S.
    Rigacci, L.
    Nassi, L.
    Puccini, B.
    Alterini, R.
    Carrai, V.
    Bernardi, F.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 532 - 532
  • [44] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
    Lin, John K.
    Muffly, Lori S.
    Spinner, Michael A.
    Barnes, James, I
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2105 - +
  • [45] Chimeric Antigen Receptor T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multicenter Study
    Tun, Aung M.
    Patel, Romil
    St-Pierre, Frederique
    Ouchveridze, Evguenia
    Niu, Alex
    Obasi, Jennifer
    Rosenthal, Allison C.
    Pophali, Priyanka A.
    Fenske, Timothy S.
    Karmali, Reem
    Ahmed, Sairah
    Johnston, Patrick B.
    BLOOD, 2023, 142
  • [46] Grading of Neurotoxicity in Patient with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) Receiving Tisagenlecleucel Treatment in the JULIET Study
    Maziarz, Richard T.
    Schuster, Stephen J.
    Romanov, Vadim V.
    Rusch, Elisha S.
    Signorovitch, James
    Ericson, Solveig G.
    Maloney, David G.
    Locke, Frederick L.
    BLOOD, 2018, 132
  • [47] Phase 1/2 trial of acalabrutinib plus pembrolizumab (Pem) in relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).
    Witzig, Thomas E.
    Maddocks, Kami J.
    De Vos, Sven
    Lyons, Roger M.
    Edenfield, William Jeffery
    Sharman, Jeff Porter
    Vose, Julie
    Yimer, Habte Aragaw
    Wei, Helen
    Chan, Edward M.
    Patel, Priti
    Di Simone, Christopher
    Gandhi, Mitul
    Vaughn, Jennifer
    Kolibaba, Kathryn
    Cheson, Bruce D.
    Samaniego, Felipe
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Sustained disease control and correlative analyses in tisagenlecleucel treated relapsed/refractory diffuse large B-Cell lymphoma patients (r/r DLBCL)
    Borchmann, P.
    Bachanova, V.
    Westin, J.
    Tam, C.
    Jaeger, U.
    McGuirk, J.
    Holte, H.
    Waller, E.
    Jaglowski, S.
    Bishop, M.
    Andreadis, C.
    Foley, S. R.
    Fleury, I.
    Teshima, T.
    Mielke, S.
    Salles, G.
    Ho, J.
    Izutsu, K.
    Maziarz, R.
    van Besein, K.
    Kersten, M. J.
    Wagner-Johnston, N.
    Kato, K.
    Corradini, P.
    Han, X.
    Agoulnik, S.
    Chu, J.
    Eldjerou, L.
    Pacaud, L.
    Schuster, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 238 - 238
  • [49] Immunogenicity of tisagenlecleucel in relapsed/ refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) patients.
    Mueller, Karen Thudium
    Grupp, Stephan A.
    Maude, Shannon L.
    Levine, John E.
    Pulsipher, Michael
    Boyer, Michael W.
    August, Keith Jason
    Myers, Gary Douglas
    Awasthi, Rakesh
    Waldron, Edward K.
    Bubuteishvili-Pacaud, Lida
    Taran, Tanya
    Cota, Mariana
    Tam, Constantine Si Lun
    Jager, Ulrich
    Foley, Ronan
    Borchmann, Peter
    Schuster, Stephen J.
    Waller, Edmund K.
    Laetsch, Theodore Willis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Additional possibilities of chimeric antigen receptor T-cells in B-cell lymphoma: combination therapy
    Yang, Yan
    Zhou, Jing
    Cao, Cong
    Cai, Panpan
    Wang, Xinxuan
    Chang, Chun
    Wang, Jingxuan
    Zhang, Qingyuan
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (11) : 7310 - 7322
12345